
    
      Data for this study is drawn from the BSTOP (Biomarkers of Systemic Treatment Outcomes in
      Psoriasis) cohort. This is a multi-centre, prospective, cohort study to establish clinically
      relevant biomarkers and pharmacogenetic markers of systemic treatment outcomes in patients
      with severe psoriasis.
    
  